Patent 7390519 was granted and assigned to Alimentary Health Limited on June, 2008 by the United States Patent and Trademark Office.
A Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome.